Keep Food Containers Safe from PFAS Act of 2026
The source supplies the latest action, but no lifecycle stage.
Latest action (24 Sep 2026): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
What this bill does
This bill, S. 5516, introduced by Senator Margaret “Maggie” Hassan, proposes to amend the Federal Food, Drug, and Cosmetic Act. Its stated purpose is to prohibit the sale of food packaging that intentionally contains PFAS chemicals into interstate commerce.
The bill would directly affect the food packaging industry and, by extension, consumers. If enacted, it would restrict the types of materials that can be used in food packaging intended for sale across state lines. The bill does not specify other potential effects or beneficiaries beyond this prohibition.
Currently, S. 5516 has been introduced in the 119th Congress. As it has just been introduced, it is in the very early stages of the legislative process. Its next steps would involve referral to a committee, potential hearings, and votes by the Senate. The full text of the bill, outlining its specific details and scope, is not yet publicly available.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
24 Sep 2026
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Common questions
- What does S. 5516 do?
- This bill, S. 5516, introduced by Senator Margaret “Maggie” Hassan, proposes to amend the Federal Food, Drug, and Cosmetic Act. Its stated purpose is to prohibit the sale of food packaging that intentionally contains PFAS chemicals into interstate commerce. The bill would directly affect the food packaging industry and, by extension, consumers. If enacted, it would restrict the types of materials that can be used in food packaging intended for sale across state lines. The bill does not specify other potential effects or beneficiaries beyond this prohibition. Currently, S. 5516 has been introduced in the 119th Congress. As it has just been introduced, it is in the very early stages of the legislative process. Its next steps would involve referral to a committee, potential hearings, and votes by the Senate. The full text of the bill, outlining its specific details and scope, is not yet publicly available.
- Has S. 5516 become law?
- The source does not supply a confirmed lifecycle stage for S. 5516. Check the latest action and official source below.
- Who sponsored S. 5516?
- S. 5516 was sponsored by Sen. Hassan, Margaret Wood [D-NH] (D-NH), with 1 cosponsor.
- What's the latest action on S. 5516?
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (24 Sep 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Hassan, Margaret Wood [D-NH]
Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act
Addiction Grants Modernization Act
Improving CARE for Youth Act
Stop Superbugs Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.